| MiCBT Research – selected studies

Development and Validation of the Equanimity Scale-16

Holly Rogers1, Alice Shires1, 2 and Bruno Cayoun2

1University of Technology, Sydney, NSW Australia
2MiCBT Institute, Hobart, TAS Australia


Abstract
Objectives: Equanimity is a non-reactive attitude that is increasingly recognized as a central component of mindfulness practice and a key mechanism of mindfulness-based interventions that is currently lacking means of measurement. The present study aimed to develop a self-report measure of equanimity, explore its underlying factor structure, validity and reliability.

Methods: An initial pool of 42 items was selected from existing mindfulness questionnaires and measures of related constructs, and subsequently reviewed by researchers and selected based on majority agreement on their construct validity. The Qualtrics online platform was used to administer these items and other questionnaires used to assess the validity and collect demographic information in 223 adults from the general individuals (66.8% females and 33.2% males, age range = 18–75). Questionnaires were then re-administered to assess test-retest reliability.

Results: In agreement with past research, exploratory factor analysis revealed two underlying factors, Experiential Acceptance and Non-reactivity. A final 16-item measure showed good internal consistency (⍺ = .88), test-retest reliability (n = 73; r = .87, p < .001) over 2–6 weeks and convergent and divergent validity, illustrated by significant correlations in the expected direction with the Nonattachment Scale, Depression Anxiety and Stress Scale, Satisfaction with Life Scale and Distress Tolerance Scale.

Conclusion: Based on this initial study, the Equanimity Scale-16 appears to be a valid and reliable self-report measure to assess trait equanimity, and may be further explored in future studies as a tool to assess progress during mindfulness-based interventions, and to assist in the investigation of their underlying mechanisms.

Read the preview here:
Mindfulness 12, 107-120 (2021)
https://doi.org/10.1007/s12671-020-01503-6

For the full article, please contact us

Group Mindfulness-Integrated Cognitive Behavior Therapy (MiCBT) Reduces Depression and Anxiety and Improves Flourishing in a Transdiagnostic Primary Care Sample Compared to Treatment-as-Usual: A Randomized Controlled Trial

June 10, 2022

Validation and Factor Structure of the Mindfulness‑Based Self Efficacy Scale‑Revised

February 7, 2022

Managing type 2 diabetes and depression with Mindfulness-integrated Cognitive Behavior Therapy (MiCBT)

February 2, 2022

The Effectiveness of Mindfulness-integrated Cognitive Behavioral Therapy (MiCBT), Meta-Cognitive Therapy (MCT), Acceptance and Commitment Therapy (ACT), and Cognitive Behavioral Therapy (CBT) on Obsessive-compulsive disorder (OCD)

October 15, 2021

Combined identification of lncRNA NONHSAG004550 and NONHSAT125420 as a potential diagnostic biomarker of perinatal depression

June 15, 2021

Co-emergence Reinforcement and Its Relevance to Interoceptive Desensitization in Mindfulness and Therapies Aiming at Transdiagnostic Efficacy

December 29, 2020

Development and Validation of the Equanimity Scale-16

October 3, 2020

Effectiveness of Mindfulness-integrated Cognitive Behavioral Therapy on the emotional states and quality of life of patients with multiple sclerosis: A clinical trial study

May 13, 2020

Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial

April 17, 2020

Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients

February 9, 2020
Scroll to Top
Login
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.